Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis

Abstract Fingolimod is an approved treatment for relapsing-remitting multiple sclerosis (MS), and its properties in different pathways have raised interest in therapy research for other neurodegenerative diseases. Fingolimod is an agonist of sphingosine-1-phosphate (S1P) receptors. Its main pharmaco...

Full description

Saved in:
Bibliographic Details
Main Authors: Pablo Bascuñana (Author), Luisa Möhle (Author), Mirjam Brackhan (Author), Jens Pahnke (Author)
Format: Book
Published: Adis, Springer Healthcare, 2020-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available